These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 10679537

  • 1. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease.
    Sin DD, Tu JV.
    Thorax; 2000 Mar; 55(3):194-7. PubMed ID: 10679537
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
    Guite HF, Dundas R, Burney PG.
    Thorax; 1999 Apr; 54(4):301-7. PubMed ID: 10092690
    [Abstract] [Full Text] [Related]

  • 3. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T, Viskum K.
    Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
    [Abstract] [Full Text] [Related]

  • 4. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
    Meier CR, Jick H.
    Thorax; 1997 Jul; 52(7):612-7. PubMed ID: 9246132
    [Abstract] [Full Text] [Related]

  • 5. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.
    Adimadhyam S, Schumock GT, Walton S, Joo M, McKell J, Lee TA.
    Pharmacotherapy; 2014 Jul; 34(4):315-23. PubMed ID: 23918239
    [Abstract] [Full Text] [Related]

  • 6. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA, Schumock GT, Bartle B, Pickard AS.
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [Abstract] [Full Text] [Related]

  • 7. Ipratropium treatment of acute airways disease.
    Peterson GM, Boyles PJ, Bleasel MD, Vial JH.
    Ann Pharmacother; 2003 Mar; 37(3):339-44. PubMed ID: 12639159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Tsukino M, Mishima M, Izumi T.
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [Abstract] [Full Text] [Related]

  • 10. Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.
    Kawasumi Y, Paterson MJ, Morrow RL, Miller TA, Bassett K, Wright JM, Dormuth CR.
    Clin Ther; 2013 Apr; 35(4):523-531.e1. PubMed ID: 23490290
    [Abstract] [Full Text] [Related]

  • 11. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A, Muir JF, Benhamou D, Weitzenblum E, Zuck P, Delacenserie R, Taytard A, Iacono P.
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [Abstract] [Full Text] [Related]

  • 12. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Feb; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 13. Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease.
    Ramsdell JW, Henderson S, Renvall MJ, Salmon DP, Ferguson P.
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):335-40. PubMed ID: 8612115
    [Abstract] [Full Text] [Related]

  • 14. Effect of ipratropium bromide on airway mucociliary function.
    Wanner A.
    Am J Med; 1986 Nov 14; 81(5A):23-7. PubMed ID: 2947458
    [Abstract] [Full Text] [Related]

  • 15. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L, de Muralt B, Schutz Y, Fitting JW.
    Thorax; 1997 Feb 14; 52(2):130-5. PubMed ID: 9059472
    [Abstract] [Full Text] [Related]

  • 16. Anticholinergic agents in asthma and COPD.
    Gross NJ.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):36-9. PubMed ID: 16488410
    [Abstract] [Full Text] [Related]

  • 17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 08; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 18. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ, Rodrigo C.
    Am J Respir Crit Care Med; 2000 Jun 08; 161(6):1862-8. PubMed ID: 10852758
    [Abstract] [Full Text] [Related]

  • 19. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V, Ambery C.
    Pulm Pharmacol Ther; 2013 Oct 08; 26(5):574-80. PubMed ID: 23524017
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.